Literature DB >> 7985082

Comparative analysis of complications from I-131 radioablation for well-differentiated thyroid cancer.

G DiRusso1, K A Kern.   

Abstract

BACKGROUND: The decision to extend thyroidectomy to the opposite lobe during resection of well-differentiated thyroid cancer should include an analysis of complications of I-131 radioablation directly related to the thyroid remnant. If significant, then contralateral resection would be indicated. To clarify this issue we studied the incidence of complications of I-131 radioablation in 63 cases of well-differentiated thyroid cancer.
METHODS: Retrospective reviews of operative notes, pathology reports, office records, and physician interviews were made. We analyzed operations, complications, and radiation dosing.
RESULTS: Procedures included unilateral thyroidectomy, 10 (15.9%); subtotal thyroidectomy, seven (11.1%); near-total thyroidectomy, 25 (39.7%); and total thyroidectomy, 21 (33.3%). The average ablative dose was 101 mCi (range, 30 to 208 mCi). Nineteen percent (12 of 63) of patients had complications including radiation thyroiditis (eight), chronic sialoadenitis (one), odynophagia (one), facial edema (one), and shingles (one). Near-total or total thyroidectomy resulted in significantly fewer complications compared with lesser resections (8.7% versus 47.1%, p < 0.005).
CONCLUSIONS: The incidence of complications of I-131 radioablation after thyroidectomy for well-differentiated thyroid cancer is related to the extent of thyroidectomy performed. We recommend contralateral thyroid resection (resulting in a near-total or total thyroidectomy) in patients likely to receive postoperative I-131 radioablation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7985082

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  6 in total

1.  Long-term course and predictive factors of elevated serum thyroglobulin and negative diagnostic radioiodine whole body scan in differentiated thyroid cancer.

Authors:  A S Alzahrani; G Mohamed; A Al Shammary; S Aldasouqi; S Abdal Salam; M Shoukri
Journal:  J Endocrinol Invest       Date:  2005-06       Impact factor: 4.256

2.  Use of radioiodine after thyroid lobectomy in patients with differentiated thyroid cancer: does it change outcomes?

Authors:  Colleen M Kiernan; Alexander A Parikh; Lee L Parks; Carmen C Solórzano
Journal:  J Am Coll Surg       Date:  2014-12-17       Impact factor: 6.113

Review 3.  The role of surgery in the management of differentiated thyroid cancer.

Authors:  S K Grebe; I D Hay
Journal:  J Endocrinol Invest       Date:  1997-01       Impact factor: 4.256

4.  Sialendoscopy for Patients with Radioiodine-Induced Sialadenitis and Xerostomia.

Authors:  Mihir K Bhayani; Varun Acharya; Suchada Kongkiatkamon; Sally Farah; Dianna B Roberts; Jennifer Sterba; Mark S Chambers; Stephen Y Lai
Journal:  Thyroid       Date:  2015-05-15       Impact factor: 6.568

5.  A Functional Scoring System Based on Salivary Gland Scintigraphy for Evaluating Salivary Gland Dysfunction Secondary to 131I therapy in Patients with Differentiated Thyroid Carcinoma.

Authors:  Yasuhiro Maruoka; Shingo Baba; Takuro Isoda; Yoshiyuki Kitamura; Koichiro Abe; Masayuki Sasaki; Hiroshi Honda
Journal:  J Clin Diagn Res       Date:  2017-08-01

6.  Short-Term Side Effects after Radioiodine Treatment in Patients with Differentiated Thyroid Cancer.

Authors:  Liyan Lu; Fengling Shan; Wenbin Li; Hankui Lu
Journal:  Biomed Res Int       Date:  2016-02-17       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.